These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7893450)

  • 1. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man.
    Martin-Rico P; Pedersen C; Skinhøj P; Nielsen C; Lindhardt BO
    AIDS; 1995 Jan; 9(1):95-6. PubMed ID: 7893450
    [No Abstract]   [Full Text] [Related]  

  • 2. Seronegative HIV disease with seroconversion at 15 months in an infant with advanced AIDS.
    Secord E; Bakshi S; Fikrig S; Pahwa S
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):350-1. PubMed ID: 11361494
    [No Abstract]   [Full Text] [Related]  

  • 3. Negative results of a rapid antibody test for HIV in a 16-month-old infant with AIDS.
    Zhang Y; Wang J; Wilson GJ; Tang YW; Lu HZ
    Ann Clin Lab Sci; 2008; 38(3):293-5. PubMed ID: 18715861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome.
    Neubert J; Laws HJ; Adams O; Münk C; Krämer M; Niehues T; Korn K; Fleckenstein B; Petri E; Borkhardt A
    AIDS; 2010 Jan; 24(2):327-8. PubMed ID: 20029271
    [No Abstract]   [Full Text] [Related]  

  • 5. Seronegative HIV-1 infection: a review of the literature.
    Spivak AM; Sydnor ER; Blankson JN; Gallant JE
    AIDS; 2010 Jun; 24(10):1407-14. PubMed ID: 20467287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Apoptosis in HIV infection].
    Maroto Vela Mdel C
    An R Acad Nac Med (Madr); 1994; 111(2):289-311; discussion 311-6. PubMed ID: 7810838
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV seronegativity in an infant with the acquired immunodeficiency syndrome.
    Quiñonez JM; Begue RE; Steele RW
    South Med J; 1998 Sep; 91(9):879-81. PubMed ID: 9743066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus infection and AIDS in a person with negative serology.
    Montagnier L; Brenner C; Chamaret S; Guétard D; Blanchard A; de Saint Martin J; Poveda JD; Pialoux G; Gougeon ML
    J Infect Dis; 1997 Apr; 175(4):955-9. PubMed ID: 9086158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relevance of phenotypic markers for progression in AIDS in HIV-1+ children].
    Zugun F; Sfartz S; Carasevici E
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(3-4):253-6. PubMed ID: 8640013
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporary seronegativity in a human immunodeficiency virus type 1-infected man.
    Zaaijer HL; Bloemer MH; Lelie PN
    J Med Virol; 1997 Jan; 51(1):80-2. PubMed ID: 8986953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of HIV vaccine development.
    Minor JR
    Am J Hosp Pharm; 1994 Jul; 51(14):1816-8. PubMed ID: 7942913
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 subtype C seronegative AIDS.
    Corcoran C; Hardie D
    Clin Infect Dis; 2008 Jan; 46(2):322-3. PubMed ID: 18171271
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression.
    Ogunro PS; Ogungbamigbe TO; Elemie PO; Egbewale BE; Adewole TA
    Niger Postgrad Med J; 2006 Mar; 13(1):1-5. PubMed ID: 16633369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters.
    Rezza G; Fiorelli V; Dorrucci M; Ciccozzi M; Tripiciano A; Scoglio A; Collacchi B; Ruiz-Alvarez M; Giannetto C; Caputo A; Tomasoni L; Castelli F; Sciandra M; Sinicco A; Ensoli F; Buttò S; Ensoli B
    J Infect Dis; 2005 Apr; 191(8):1321-4. PubMed ID: 15776379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgently needed: a filter for the HIV-1 vaccine pipeline.
    Moore JP; Burton DR
    Nat Med; 2004 Aug; 10(8):769-71. PubMed ID: 15286768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 causing AIDS and death in a seronegative individual.
    Soriano V; Dronda F; González-López A; Chaves F; Bravo R; Gutiérrez M; Heredia A; Hewlett I
    Vox Sang; 1994; 67(4):410-1. PubMed ID: 7701817
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda.
    Epstein H; Guay L; Hom D; Mmiro F; Ndugwa C; Marum L; Olness K; Piwowar E; Kataaha P; Baenziger J
    Pediatr AIDS HIV Infect; 1994 Dec; 5(6):350-6. PubMed ID: 11361376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.